140 participants
Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-11
- Start Date:
- 2021-08-27
- Completion:
- 2027-07-31
Conditions
- Schizophrenia
- Schizo-Affective Disorder
- Schizophreniform; Schizophrenic
- Bipolar Disorder I
- Bipolar Disorder II
Interventions
- DRUG
No Results Yet